Pharma logistics undergoes a new phase
The pharma logistics sector is undergoing significant changes as temperature-sensitive air cargo becomes increasingly vital to the global supply chain. There is a growing demand from pharmaceutical and biotech industries, necessitating more resilient, connected, and adaptable cold chain solutions. Delphine Perridy, the chief commercial officer at Envirotainer, points out that the market evolution is marked by a shift towards long-term demand patterns, driven by global clinical trial expansions, increased production of temperature-sensitive biologics, and the adoption of direct-to-patient delivery models.
In response to these changes, companies are moving away from single-use packaging towards solutions that provide enhanced visibility, reliability, and cost efficiency. Envirotainer has introduced the Releye RKN container, which offers market-leading autonomy exceeding 130 hours, ensuring cargo protection even in the face of unforeseen delays or supply chain disruptions. This product line includes real-time visibility features and a focus on reducing carbon emissions.
Alongside active units, Envirotainer has broadened its offerings to include advanced passive solutions following the integration of va-Q-tec’s pharma business. The company’s strategic station growth, currently at 100 stations, allows for quick setup in new locations to meet demand. Compliance with GDP and CEIV standards is now seen as essential rather than optional. Perridy emphasizes the importance of certification as a baseline requirement for businesses as a significant amount of pharmaceuticals are wasted annually due to inadequate preparation for temperature fluctuations.
The increasing frequency of climate events and geopolitical uncertainties have added complexity to supply chains. Medications are exposed to extreme temperatures and diverse infrastructure during transit, making it crucial to find suitable logistics solutions. Predictive tools, such as AI and analytics, are highlighted as critical in foreseeing and preventing disruptions, minimizing downtime, and ensuring continuous reliability.
Envirotainer’s focus on human monitoring is evident through its Releye solution, which offers real-time live monitoring and a 24/7 Control Tower service to track shipments and respond to critical events promptly. Perridy stresses the importance of collaboration among stakeholders to build resilience into operations and overcome challenges caused by silos.
The evolving demand profile in cold chain logistics includes a shift towards specialized and individualized treatments that are often moved over shorter distances in small, high-value shipments. Technology innovation plays a crucial role in enhancing transparency and efficiency within the industry. While AI adoption takes time, Perridy emphasizes the importance of global accessibility to pharmaceuticals, regardless of geopolitical tensions. Enabling global access to vital medications remains a key focus for Envirotainer, reflecting the company’s commitment to serving the needs of individuals worldwide.